Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure

BACKGROUND AND AIMS: Nonbiological artificial liver (NBAL) is frequently used as a first-line treatment for hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF). This study aimed to compare the therapeutic efficacy and cost-effectiveness ratio (CER) of comprehensive medical treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Cichun, Peng, Wenting, Cheng, Da, Gu, Huimin, Liu, Fei, Peng, Shifang, Fu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817044/
https://www.ncbi.nlm.nih.gov/pubmed/36643036
http://dx.doi.org/10.14218/JCTH.2022.00106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817044/
https://www.ncbi.nlm.nih.gov/pubmed/36643036
http://dx.doi.org/10.14218/JCTH.2022.00106

Ejemplares similares